Intellia presses forward with new results for pioneering CRISPR drug
Bio Pharma Dive
FEBRUARY 28, 2022
The findings build on early evidence that gene editing inside the body could safely and effectively treat disease, and suggest the effects of Intellia's medicine might last.
Let's personalize your content